small molecule glp-1 receptor agonist Figure 1 from Drug Discovery at the Glucagon-Like Peptide-1 BioWorld
Description
So what is microdosing GLP-1, exactly

However, rare side effects exist and require attention

StatPearls NCBI Bookshelf

Suboptimal Treatment Response with AOMs Once a treatment has been initiated, it is important to consider what to do in the event of a suboptimal treatment response

Mounjaro (tirzepatide) injection, for subcutaneous use: prescribing information [Internet]

Restricted studies integrating GLP-1 receptor agonists with alternative anti-obesity pharmaceuticals (e.g., GIP agonists, amylin analogs)
